Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Oncology|May 11, 2012
A pilot study of long-acting octreotide for symptomatic malignant ascitesAminah Jatoi, Jorge J Nieva, Rui Qin, et al.
Cancer|November 6, 2003
Reoperations after prophylactic mastectomy with or without implant reconstructionSara M Zion, Jeffrey M Slezak, Thomas A Sellers, et al.
Breast Cancer Research and Treatment|July 2, 2008
Lobular involution: localized phenomenon or field effect?Robert A Vierkant, Lynn C Hartmann, V Shane Pankratz, et al.
Oncology Nursing Forum|November 7, 2003
Stories of breast cancer through artJulie A Ponto, Marlene H Frost, Romayne Thompson, et al.
Cancer|December 20, 2002
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriersCamilo Adem, Carol Reynolds, Cheryl L Soderberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Association between mammographic density and age-related lobular involution of the breastKarthik Ghosh, Lynn C Hartmann, Carol Reynolds, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 17, 2011
p16(INK4a) expression and breast cancer risk in women with atypical hyperplasiaDerek C Radisky, Marta Santisteban, Hal K Berman, et al.
Cancer Immunology, Immunotherapy : CII|August 24, 2015
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancerKeith L Knutson, Matthew J Maurer, Claudia C Preston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Estrogen bioactivation, genetic polymorphisms, and ovarian cancerThomas A Sellers, Joellen M Schildkraut, V Shane Pankratz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Model for individualized prediction of breast cancer risk after a benign breast biopsyV Shane Pankratz, Amy C Degnim, Ryan D Frank, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Oncology|May 11, 2012
A pilot study of long-acting octreotide for symptomatic malignant ascitesAminah Jatoi, Jorge J Nieva, Rui Qin, et al.
Cancer|November 6, 2003
Reoperations after prophylactic mastectomy with or without implant reconstructionSara M Zion, Jeffrey M Slezak, Thomas A Sellers, et al.
Breast Cancer Research and Treatment|July 2, 2008
Lobular involution: localized phenomenon or field effect?Robert A Vierkant, Lynn C Hartmann, V Shane Pankratz, et al.
Oncology Nursing Forum|November 7, 2003
Stories of breast cancer through artJulie A Ponto, Marlene H Frost, Romayne Thompson, et al.
Cancer|December 20, 2002
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriersCamilo Adem, Carol Reynolds, Cheryl L Soderberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Association between mammographic density and age-related lobular involution of the breastKarthik Ghosh, Lynn C Hartmann, Carol Reynolds, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 17, 2011
p16(INK4a) expression and breast cancer risk in women with atypical hyperplasiaDerek C Radisky, Marta Santisteban, Hal K Berman, et al.
Cancer Immunology, Immunotherapy : CII|August 24, 2015
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancerKeith L Knutson, Matthew J Maurer, Claudia C Preston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Estrogen bioactivation, genetic polymorphisms, and ovarian cancerThomas A Sellers, Joellen M Schildkraut, V Shane Pankratz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Model for individualized prediction of breast cancer risk after a benign breast biopsyV Shane Pankratz, Amy C Degnim, Ryan D Frank, et al.
Pageof 15